Centro Medico Dalinde
Cdmx, Mexico CITY (federal District), Mexico
Medical center in Mexico City
Quintana Roo 92, Roma Sur, Cuauhtémoc, 06760 Ciudad de México, CDMX
About Centro Medico Dalinde
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Rigel Pharmaceuticals
2
Ethicon Endo-Surgery
1
Ferring Pharmaceuticals
1
Clinical Trials at Centro Medico Dalinde
During the past decade, Centro Medico Dalinde conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
2006-08-01
2007-12-01
Completed
189
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis
2008-05-01
2009-06-01
Completed
457
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
2018-01-11
2024-01-31
Recruiting
572
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Dalinde"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Centro Medico Dalinde
According to Clinical.Site data, the most researched conditions in "Centro Medico Dalinde" are
"Breast Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Cancer" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Centro Medico Dalinde" in a lesser frequency.
Clinical Trials Intervention Types at Centro Medico Dalinde
Most popular intervention types in "Centro Medico Dalinde" are "Drug" (11 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Atezolizumab" (5 trials), "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Medico Dalinde
The vast majority of trials in "Centro Medico Dalinde" are
11 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centro Medico Dalinde
Currently, there are NaN active trials in "Centro Medico Dalinde".
undefined are not yet recruiting,
3 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Centro Medico Dalinde,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro Medico Dalinde, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".